Shares in Decode Slide 7.7 Percent on Q4 Revenue Decline, Widened Loss | GenomeWeb

NEW YORK, March 7(GenomeWeb News) - Shares in Decode Genetics were down 7.74 percent, or $.73 at $8.70 in mid-afternoon trading after the company yesterday reported an approximately 13-percent decrease in revenues amid escalating losses for the fourth quarter.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.

An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.

The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.

For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.